Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    181845 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Conditions: Kidney Neoplasm;   Lung Neoplasm;   Sarcoma;   Breast Neoplasm
Interventions: Biological: rh IL-12;   Biological: rh IL-2
2 Completed Ultra Low Dose Interleukin-2 in Healthy Volunteers
Condition: Hematologic Diseases
Interventions: Drug: Interleukin-2 (100,000 international units);   Drug: Interleukin-2 (200,000 international units)

Study has passed its completion date and status has not been verified in more than two years.